PL1710245T3 - Postać krystaliczna maleinianu asenapiny - Google Patents

Postać krystaliczna maleinianu asenapiny

Info

Publication number: PL1710245T3
Authority: PL; Poland
Prior art keywords: crystal form; asenapine maleate; asenapine; maleate; crystal
Prior art date: 2005-04-07

Application number

PL06112332T

Other languages

English (en)

Inventor

Gerhardus Johannes Heeres

Original Assignee

Merck Sharp & Dohme

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-04-07

Filing date

2006-04-06

Publication date

2008-01-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36617328&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1710245(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-04-06 Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme

2008-01-31 Publication of PL1710245T3 publication Critical patent/PL1710245T3/pl

Links

GMDCDXMAFMEDAG-CHHFXETESA-N (S,S)-asenapine maleate Chemical compound OC(=O)\C=C/C(O)=O.O1C2=CC=CC=C2[C@H]2CN(C)C[C@@H]2C2=CC(Cl)=CC=C21 GMDCDXMAFMEDAG-CHHFXETESA-N 0.000 title 1
229960001615 asenapine maleate Drugs 0.000 title 1
239000013078 crystal Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
Hydrogenated Pyridines (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

PL06112332T 2005-04-07 2006-04-06 Postać krystaliczna maleinianu asenapiny PL1710245T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP05102742		2005-04-07
EP05102969		2005-04-14
EP06112332A EP1710245B1 (en)	2005-04-07	2006-04-06	Crystal form of asenapine maleate

Publications (1)

Publication Number	Publication Date
PL1710245T3 true PL1710245T3 (pl)	2008-01-31

Family

ID=36617328

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL06112332T PL1710245T3 (pl)	2005-04-07	2006-04-06	Postać krystaliczna maleinianu asenapiny
PL06725622T PL1917267T3 (pl)	2005-04-07	2006-04-06	Postać krystaliczna maleinianu asenapiny

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
PL06725622T PL1917267T3 (pl)	2005-04-07	2006-04-06	Postać krystaliczna maleinianu asenapiny

Country Status (31)

Country	Link
EP (2)	EP1917267B1 (pl)
JP (1)	JP5058151B2 (pl)
KR (1)	KR101422843B1 (pl)
AR (1)	AR056306A1 (pl)
AT (2)	ATE370954T1 (pl)
AU (1)	AU2006231617B2 (pl)
BR (1)	BRPI0609741A8 (pl)
CA (1)	CA2603509C (pl)
CY (2)	CY1106902T1 (pl)
DE (2)	DE602006000080T2 (pl)
DK (2)	DK1710245T3 (pl)
DO (1)	DOP2006000082A (pl)
ES (2)	ES2318742T3 (pl)
GT (1)	GT200600135A (pl)
HN (1)	HN2006014095A (pl)
HR (1)	HRP20070429T3 (pl)
IL (1)	IL186355A (pl)
MX (1)	MX2007012445A (pl)
MY (1)	MY137969A (pl)
NO (1)	NO340520B1 (pl)
NZ (1)	NZ562124A (pl)
PE (1)	PE20061311A1 (pl)
PL (2)	PL1710245T3 (pl)
PT (2)	PT1917267E (pl)
RS (1)	RS50532B (pl)
RU (1)	RU2405786C2 (pl)
SI (2)	SI1710245T1 (pl)
SV (1)	SV2006002473A (pl)
TW (1)	TWI364423B (pl)
UY (1)	UY29459A1 (pl)
WO (1)	WO2006106135A1 (pl)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TW200831514A (en) *	2006-10-06	2008-08-01	Organon Nv	Amorphous asenapine and processes for preparing same
MX2012000061A (es) *	2009-06-24	2012-06-01	Msd Oss Bv	Formulaciones inyectables que contienen asenapina, y metodo de tratamiento usando las mismas.
WO2011159903A2 (en)	2010-06-18	2011-12-22	Dr. Reddy's Laboratories Ltd.	Asenapine maleate
WO2012066565A2 (en) *	2010-11-16	2012-05-24	Cadila Healthcare Limited	Asenapine maleate amorphous and crystalline form and process for preparation thereof
EP2468750A1 (en)	2010-12-13	2012-06-27	Chemo Ibérica, S.A.	Polymorphic forms of asenapine maleate and processes for their preparation
WO2012123325A1 (en)	2011-03-11	2012-09-20	Medichem S.A.	NEW CRYSTAL FORMS OF THE SALT OF TRANS-5-CHLORO-2-METHYL-2,3,3A,12b-TETRAHYDRO-1H-DIBENZO[2,3:6,7]OXEPINO[4,5-c]PYRROLE WITH MALEIC ACID
ITMI20110734A1 (it) *	2011-05-02	2012-11-03	Olon Spa	Sali cristallini di asenapina
EP2524921A1 (en)	2011-05-17	2012-11-21	Sandoz AG	Novel Crystalline Salts of Asenapine
EP2524919A1 (en)	2011-05-17	2012-11-21	Sandoz AG	Novel crystalline salts of Asenapine with organic Di-acids and Tri-acids
EP2524920A1 (en)	2011-05-17	2012-11-21	Sandoz AG	Novel Crystalline Asenapine Hydrochloride Salt Forms
US9505771B2 (en) *	2011-05-18	2016-11-29	Laboratories Lesvi S.L.	Stable micronised monoclin form of asenapine maleate and its synthesis
EP2709615A1 (en)	2011-05-18	2014-03-26	Laboratorios Lesvi, S.L.	Monoclinic crystalline form of asenapine maleate with a specific particle size distribution
EP2572703A1 (en)	2011-09-21	2013-03-27	Hexal AG	Compressed oral dosage form for asenapine maleate
WO2013041604A1 (en)	2011-09-21	2013-03-28	Sandoz Ag	Crystal form of asenapine maleate
CN104507472B (zh) *	2012-07-26	2016-10-05	久光制药株式会社	贴附剂
ITMI20121810A1 (it)	2012-10-24	2014-04-25	Chemo Iberica Sa	Poliformi di maleato di asenapina e processo per la loro preparazione
US9597291B2 (en)	2012-12-11	2017-03-21	Alfred E. Tiefenbacher (Gmbh & Co. Kg)	Orally disintegrating tablet containing asenapine
WO2014127786A1 (en)	2013-02-22	2014-08-28	Zentiva, K.S.	Orally disintegrating pharmaceutical composition comprising asenapine
WO2017037718A1 (en)	2015-09-02	2017-03-09	Eloxx Pharmaceuticals Ltd.	Aminoglycoside derivatives and uses thereof in treating genetic disorders
ES3001152T3 (es)	2016-12-20	2025-03-04	Lts Lohmann Therapie Systeme Ag	Sistema terapéutico transdérmico que contiene asenapina y polisiloxano o poliisobutileno
PL3338768T3 (pl)	2016-12-20	2020-05-18	Lts Lohmann Therapie-Systeme Ag	Transdermalny system terapeutyczny zawierający asenapinę
WO2019002204A1 (en)	2017-06-26	2019-01-03	Lts Lohmann Therapie-Systeme Ag	TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND SILICONE-TYPE ACRYLIC HYBRID POLYMER
EP3810099A1 (en)	2018-06-20	2021-04-28	LTS Lohmann Therapie-Systeme AG	Transdermal therapeutic system containing asenapine
AU2019291060B2 (en)	2018-06-20	2024-09-05	Lts Lohmann Therapie-Systeme Ag	Transdermal therapeutic system containing asenapine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL7605526A (nl) *	1976-05-24	1977-11-28	Akzo Nv	Nieuwe tetracyclische derivaten.
CN1079670C (zh) *	1994-03-02	2002-02-27	阿克佐诺贝尔公司	舌下或颊给药的药物组合物
WO1999032108A1 (en) *	1997-12-19	1999-07-01	Akzo Nobel N.V.	Org-5222 in the treatment of depression
TWI327915B (en) *	2003-06-12	2010-08-01	Organon Nv	Pharmaceutical composition comprising antipsychotic agent and use of the antipsychotic agent for treating patients with overweight

2006
- 2006-04-06 PL PL06112332T patent/PL1710245T3/pl unknown
- 2006-04-06 SI SI200630006T patent/SI1710245T1/sl unknown
- 2006-04-06 EP EP06725622A patent/EP1917267B1/en not_active Expired - Lifetime
- 2006-04-06 SV SV2006002473A patent/SV2006002473A/es unknown
- 2006-04-06 DK DK06112332T patent/DK1710245T3/da active
- 2006-04-06 HN HN2006014095A patent/HN2006014095A/es unknown
- 2006-04-06 ES ES06725622T patent/ES2318742T3/es not_active Expired - Lifetime
- 2006-04-06 MX MX2007012445A patent/MX2007012445A/es active IP Right Grant
- 2006-04-06 DE DE602006000080T patent/DE602006000080T2/de not_active Expired - Lifetime
- 2006-04-06 RU RU2007141198/04A patent/RU2405786C2/ru active Protection Beyond IP Right Term
- 2006-04-06 EP EP06112332A patent/EP1710245B1/en not_active Expired - Lifetime
- 2006-04-06 PT PT06725622T patent/PT1917267E/pt unknown
- 2006-04-06 WO PCT/EP2006/061408 patent/WO2006106135A1/en not_active Ceased
- 2006-04-06 BR BRPI0609741A patent/BRPI0609741A8/pt not_active IP Right Cessation
- 2006-04-06 AU AU2006231617A patent/AU2006231617B2/en not_active Expired
- 2006-04-06 DK DK06725622T patent/DK1917267T3/da active
- 2006-04-06 DE DE602006004463T patent/DE602006004463D1/de not_active Expired - Lifetime
- 2006-04-06 PL PL06725622T patent/PL1917267T3/pl unknown
- 2006-04-06 ES ES06112332T patent/ES2293626T3/es not_active Expired - Lifetime
- 2006-04-06 SI SI200630190T patent/SI1917267T1/sl unknown
- 2006-04-06 KR KR1020077025428A patent/KR101422843B1/ko not_active Expired - Lifetime
- 2006-04-06 MY MYPI20061554A patent/MY137969A/en unknown
- 2006-04-06 GT GT200600135A patent/GT200600135A/es unknown
- 2006-04-06 AT AT06112332T patent/ATE370954T1/de active
- 2006-04-06 AT AT06725622T patent/ATE418556T1/de active
- 2006-04-06 JP JP2008504776A patent/JP5058151B2/ja not_active Expired - Lifetime
- 2006-04-06 PT PT06112332T patent/PT1710245E/pt unknown
- 2006-04-06 NZ NZ562124A patent/NZ562124A/en unknown
- 2006-04-06 RS RSP-2007/0436A patent/RS50532B/sr unknown
- 2006-04-06 TW TW095112187A patent/TWI364423B/zh active
- 2006-04-06 UY UY29459A patent/UY29459A1/es not_active Application Discontinuation
- 2006-04-06 AR ARP060101358A patent/AR056306A1/es not_active Application Discontinuation
- 2006-04-06 DO DO2006P000082A patent/DOP2006000082A/es unknown
- 2006-04-06 CA CA2603509A patent/CA2603509C/en not_active Expired - Lifetime
- 2006-04-06 PE PE2006000377A patent/PE20061311A1/es active IP Right Grant
2007
- 2007-09-19 HR HR20070429T patent/HRP20070429T3/xx unknown
- 2007-10-02 CY CY20071101258T patent/CY1106902T1/el unknown
- 2007-10-07 IL IL186355A patent/IL186355A/en active IP Right Grant
- 2007-10-10 NO NO20075142A patent/NO340520B1/no unknown
2009
- 2009-01-30 CY CY20091100111T patent/CY1108742T1/el unknown

Also Published As

Publication number	Publication date
TWI364423B (en)	2012-05-21
RU2405786C2 (ru)	2010-12-10
NO340520B1 (no)	2017-05-02
JP2008534656A (ja)	2008-08-28
NZ562124A (en)	2010-07-30
UY29459A1 (es)	2006-11-30
DE602006004463D1 (de)	2009-02-05
MX2007012445A (es)	2007-11-07
EP1917267B1 (en)	2008-12-24
AU2006231617A1 (en)	2006-10-12
BRPI0609741A8 (pt)	2018-03-13
PE20061311A1 (es)	2007-02-09
CA2603509C (en)	2013-12-03
NO20075142L (no)	2007-11-05
PT1917267E (pt)	2009-02-04
DOP2006000082A (es)	2006-11-30
EP1917267A1 (en)	2008-05-07
SV2006002473A (es)	2009-11-24
RS50532B (sr)	2010-05-07
DE602006000080T2 (de)	2008-05-15
BRPI0609741A2 (pt)	2010-04-27
JP5058151B2 (ja)	2012-10-24
KR20080005253A (ko)	2008-01-10
SI1710245T1 (sl)	2007-12-31
CA2603509A1 (en)	2006-10-12
AU2006231617B2 (en)	2010-06-03
WO2006106135A1 (en)	2006-10-12
PL1917267T3 (pl)	2009-06-30
HN2006014095A (es)	2010-08-19
MY137969A (en)	2009-04-30
EP1710245B1 (en)	2007-08-22
IL186355A0 (en)	2008-01-20
DK1917267T3 (da)	2009-04-14
IL186355A (en)	2016-05-31
AR056306A1 (es)	2007-10-03
CY1108742T1 (el)	2014-04-09
DK1710245T3 (da)	2007-12-03
HRP20070429T3 (en)	2007-11-30
ES2293626T3 (es)	2008-03-16
GT200600135A (es)	2006-11-07
DE602006000080D1 (de)	2007-10-04
PT1710245E (pt)	2007-10-03
KR101422843B1 (ko)	2014-07-24
SI1917267T1 (sl)	2009-04-30
ES2318742T3 (es)	2009-05-01
CY1106902T1 (el)	2012-09-26
RU2007141198A (ru)	2009-05-20
ATE370954T1 (de)	2007-09-15
EP1710245A1 (en)	2006-10-11
TW200722428A (en)	2007-06-16
ATE418556T1 (de)	2009-01-15

Publication	Publication Date	Title
ZA200708493B (en)	2009-09-30	Crystal form of asenapine maleate
IL186355A0 (en)	2008-01-20	Crystal form of asenapine maleate
PL1992697T3 (pl)	2010-08-31	Wytwarzanie TNFR-Fc
IL181587A0 (en)	2007-07-04	Production of ??-abeta
SI1636190T1 (sl)	2012-09-28	Stabilni kristal 4-oksokinolinske spojine
EG26462A (en)	2013-11-13	Polypeptide production
SI1802579T1 (sl)	2014-03-31	Derivati 3-arilaminopiridina
PT1778618E (pt)	2014-03-04	Síntese de trietilenotetraminas
IL185757A0 (en)	2008-01-06	Methods of decreasing calcifcation
PL1737304T3 (pl)	2014-10-31	Zagęszczona płynna formuła
WO2007038678A8 (en)	2008-06-19	Analogs of ghrelin
ZAF200500440S (en)	2005-10-04	Chlorinators
EP1711484A4 (en)	2007-06-20	SYNTHESIS OF CYANOIMINO-BENZOIMIDAZOLES
GB0410498D0 (en)	2004-06-16	Crystal
ZA200702731B (en)	2008-06-25	Production of ferro-alloys
SI1812422T1 (sl)	2014-05-30	Kristalna oblika irbesartana
SI1814858T1 (sl)	2015-10-30	Nove kristalne oblike nelfinavir mesilata
IL178184A0 (en)	2006-12-31	Synthesis of pyrrole-2-carbonitriles
IL187326A0 (en)	2008-04-13	Crystalline form of benzazepinium maleate derivative
ZA200508325B (en)	2008-05-28	Manufacture of kerbstones
GB0425914D0 (en)	2004-12-29	Improvements relating to foundations
GB0508526D0 (en)	2005-06-01	Crystal structure
GB0508123D0 (en)	2005-06-01	Crystal structure
AU2004906453A0 (en)	2004-11-25	Production of ferro-allays
AU2005900755A0 (en)	2005-03-03	Improvements relating to pendulum packers